Updates in Breast Cancer from San Antonio
SABCS 2019 Highlights on ER+ mBC: Palbociclib + ET Is Better Tolerated Than Capecitabine, but not More Effective + Menopausal Estrogen Replacement Reduced BC Risk and Mortality
By
Updates in Breast Cancer from San Antonio
FEATURING
Jennifer Matro
By
Updates in Breast Cancer from San Antonio
FEATURING
Jennifer Matro
Login to view comments.
Click here to Login
Videos